Live News EQUITY FLASH L impact Nov 05, 2026, 10:34 AM UTC InnoCare Says Orelabrutinib Phase III ITP Study Met Primary Endpoint Valid market news retained in the public archive without immediate LiveCast distribution. SquawkNews Desk